Remove 2021 Remove Immunization Remove Labelling
article thumbnail

Current and future players in the lupus market

Pharmaceutical Technology

The management of SLE and LN consists largely of treatment options that are based on highly efficacious steroids or immune-suppressive therapy with an undesirable safety profile, which includes accrued organ damage, infections and cancer. in 2018 across the 7MM despite being an off-label therapy for lupus.

Labelling 111
article thumbnail

Dupixent face rash and redness: Causes and treatment

The Checkup by Singlecare

How Dupixent works in the body It’s still unclear what causes atopic dermatitis , the most common form of adult and pediatric eczema, but it’s commonly regarded as an immune system and skin barrier condition. Those intruders trigger the immune system, which releases certain proteins that cause skin inflammation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Legislation Would Cut Off Access To The Courts And Immunize FDA Actions From Timely Judicial Review

The FDA Law Blog

Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. And in December 2021, we saw FDA apply those factors in responding to a citizen petition (Docket No.

article thumbnail

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

pharmaphorum

Happy to announce that @EU_Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with @BioNTech_Group @Pfizer for 2021-2023. — Ursula von der Leyen (@vonderleyen) May 8, 2021. Other contracts and other vaccine technologies will follow.

Vaccines 122
article thumbnail

Phase III trial shows tislelizumab improves outcomes for liver cancer patients

European Pharmaceutical Review

The RATIONALE 301 Phase III randomised, open-label study included more than 600 patients in the US, Europe and Asia. receptors on macrophages, helping the body’s immune cells to detect and fight tumours. The primary endpoint of non-inferiority of overall survival (OS) between the two groups of patients was met, BeiGene said.

article thumbnail

Dupixent eye side effects: What they are and why they happen

The Checkup by Singlecare

Biologics are designed to target specific immune system proteins that can cause certain reactions. The immune system releases those proteins in response to potential allergens entering the body. This causes the immune system to overreact, leading to skin irritation.

article thumbnail

FDA awards full approval to Paxlovid amidst hazy coverage plans

Pharmaceutical Technology

The label is specified for the treatment of “mild-to-moderate Covid-19 in adults who are at high risk for progression to severe COVID-19, including hospitalisation or death.” The FDA first granted the drug under an emergency use authorisation (EUA) during the pandemic in December 2021.

FDA 59